Steve Teo

Parenteral Anticoagulants

Platelet factor 4–induced T _H 1-T _reg polarization suppresses antitumor immunity

Parenteral Anticoagulants

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

Perioperative Management of Antithrombotic Therapy

Antithrombotic Therapy for VTE Disease

Antithrombotic Therapy for VTE Disease

Heparin and Low-Molecular-Weight Heparin

Heparin and Low-Molecular-Weight Heparin

How were new medicines discovered?

Heparin-induced thrombocytopenia and cardiac surgery

The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer

Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Advances in the Pharmacotherapy of Attention‐Deficit‐Hyperactivity Disorder: Focus on Methylphenidate Formulations

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

A 90-day oral gavage toxicity study of d-methylphenidate and d,l-methylphenidate in Sprague–Dawley rats

Reversal of Heparin Anticoagulation by Recombinant Platelet Factor 4 in Humans